Search
Mink Therapeutics Inc
INKTAdd to Watchlist
12.350USD
+0.240+1.98%
Close 09-23 16:00（ET）
61.50MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
+1.98%
5 Days
+6.56%
1 Month
+1.23%
6 Months
+40.02%
Year to Date
+10.76%
1 Year
-17.23%
Key Figures
12.500Open
12.500High
263.00Volume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.01%Turnover Ratio
12.110Prev. Close
11.680Low
3.21KTurnover
LossP/E Static
-4.29P/B
0.00%Div Yield TTM
-170.30%ROA
16.92752wk High
0.05Volume Ratio
-10.78MNet Profit
4.98MShares
-2.7995EPS TTM
0.47Beta
-1238.98%ROE
8.48052wk Low
7.26%Amplitude
--Gross Margin
61.50MMarket Cap
1.10Reward/Risk
4.62%Risk Rate
Analyst Rating
Mink Therapeutics Inc Technical Analysis
Technical Indicators
Buy
Summary
Buy
Moving Average
Strong buy
Mink Therapeutics Inc Latest Earnings Call Transcripts
MiNK Therapeutics (INKT) Q2 2026 Earnings Call: agenT-797 ARDS Trial Advances
MiNK Therapeutics Q2 2026 earnings call: net loss narrowed to $3.1 million, cash ended at $8.8 million, and agenT-797 Phase 2 ARDS data are due in early 2027.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.62/-0.60
Revenue / Forecast
--/0.00
Mink Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolINKT
Number of employees23
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Agenus, Inc. | 43.70% |
| GKCC, LLC | 9.31% |
| Armen (Garo H.) | 3.47% |
| Vanguard Capital Management, LLC | 1.19% |
| Shareholder Types | Proportion |
|---|---|
| Corporation | 53.02% |
| Individual Investor | 7.38% |
| Investment Advisor | 2.62% |
| Investment Advisor/Hedge Fund | 0.29% |
Related Instruments
-1.64%
-0.01%
-0.05%
-1.88%
+1.01%
-2.99%
-1.01%
-0.85%
-3.12%
+0.90%
+0.26%
-1.77%
-1.20%
-2.00%
-1.99%
-0.26%
-0.25%
-0.74%
-1.86%
-0.35%Popular Instruments
51359.200
-130.800 (-0.25%)
30194.600
-283.300 (-0.93%)
7666.400
-40.600 (-0.53%)
14260.000
-162.000 (-1.12%)
65483.000
-646.000 (-0.98%)
6291.400
+1.400 (+0.02%)
92.673
+0.183 (+0.20%)
337.020
-2.730 (-0.80%)
225.510
-3.360 (-1.47%)
4258.620
-27.620 (-0.64%)
FAQs
What is the current price of Mink Therapeutics Inc (INKT)?
The current price of Mink Therapeutics Inc (INKT) is 12.35.
What is the symbol of Mink Therapeutics Inc?
The ticker symbol of Mink Therapeutics Inc is INKT.
What is the 52-week high of Mink Therapeutics Inc?
The 52-week high of Mink Therapeutics Inc is 16.93.
What is the 52-week low of Mink Therapeutics Inc?
The 52-week low of Mink Therapeutics Inc is 8.48.
What is the market capitalization of Mink Therapeutics Inc?
The market capitalization of Mink Therapeutics Inc is 61.50M.
Is Mink Therapeutics Inc (INKT) currently rated as Buy, Hold, or Sell?
According to analysts, Mink Therapeutics Inc (INKT) has an overall rating of Buy, with a price target of 39.00.
What is the Earnings Per Share (EPS TTM) of Mink Therapeutics Inc (INKT)?
The Earnings Per Share (EPS TTM) of Mink Therapeutics Inc (INKT) is -2.80.